de la Fuente J M, Lotstra F
Department of Psychiatry, Erasme Hospital, Free University of Brussels (ULB), Belgium.
Eur Neuropsychopharmacol. 1994 Dec;4(4):479-86. doi: 10.1016/0924-977x(94)90296-8.
Borderline personality disorder does not have a first choice pharmacological treatment. We studied 20 borderline inpatients in a double-blind parallel placebo-controlled trial with carbamazepine for a mean of 30.9 days. No significant positive effects of the drug were found.
边缘型人格障碍没有首选的药物治疗方法。我们在一项双盲平行安慰剂对照试验中，对20名边缘型人格障碍住院患者使用卡马西平进行了平均30.9天的研究。未发现该药物有显著的积极效果。
